Posts in category

Mortgage Blog


The former St. Peter’s CEO led one of area’s biggest mergers. He says more local consolidation is likely in the industry.

The deal means over 66,000 patients with Cigna insurance can receive in-network services from St. Luke’s Health hospitals or Baylor College of Medicine doctors.

PNC economists stick with mild recession forecast, differ with central bank on the number of rate hikes ahead.

After first expanding into Houston last November, San Antonio-based Vantage Bank has hired a co-market president for the region as the company looks to make Houston its largest market.

Bright Health Group Inc. (NYSE:BHG) plans to lay off an additional 68 employees at its Bloomington headquarters, after the company recently eliminated nearly 100 positions.

The permanent layoffs are attributed to a “reduction in force initiative” at its headquarters, located at 8000 Norman Center Drive, and will take place April 1, according to a notice sent to the Minnesota Department of Employment and Economic Development by Bright. Companies with 50 or more employees must report large-scale…

McClain Bryant Macklin recently took on a new role that she says will help bridge Health Forward Foundation's grant awards with its policy and advocacy leadership. The goal is to address the root causes of challenges in a community rather than simply throw money at it.

It's been one year since the opening of Aurora Health Care's $228 million medical center in Mount Pleasant adjacent to the Foxconn Technology Group campus, with the new facility admitting nearly 1,800 patients by year-end 2022.

Drs. Angela Moore and Neal Secrist opened Evolve Healthcare in early January near 37th Street North and Ridge Road.

Precigen Inc. (NASDAQ: PGEN) has raised $75 million in a public offering that closed Friday and intends to use the proceeds to speed development of its experimental treatments for multiple rare diseases.

The clinical-stage biotech, which is developing gene and cell therapies for cancers, autoimmune disorders and infectious diseases, sold 42.86 million shares of common stock for $1.75 each. The company also gave the underwriters an option to buy up to 6.43 million additional shares in the 30 days…